Paraneoplastic Neurological Syndrome in a Patient with Limited-stage Small-cell Lung Cancer Receiving Durvalumab Maintenance after Concurrent Chemoradiotherapy: A Case Report.
Paraneoplastic neurological syndromes (PNSs) are immune-mediated disorders associated with small-cell lung cancer (SCLC). Durvalumab following concurrent chemoradiotherapy (cCRT) improves outcomes in patients with limited-stage SCLC (LS-SCLC); however, its safety in patients with pre-existing PNS and residual neurologi...